GlassScriptPhysician profile
Christy M James
NPI 1801312657
$15,896.51
in general payments reported to CMS, 2019-2025
66 companies · $4,584 in 2025
The $4,584 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,036 · 2022: $3,100 · 2023: $2,559 · 2024: $2,618 · 2025: $4,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,756 · Education: $5.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,755.55 |
| Education | $5.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $3,335.64 | 2021-2025 | Austedo Xr, Austedo, Austedo Xr |
| Abbvie INC. | $2,176.79 | 2021-2025 | |
| Ucb, INC. | $745.37 | 2021-2025 | Nayzilam, Fintepla, Briviact |
| Abbott Laboratories | $740.36 | 2021-2025 | Proclaim |
| Alexion Pharmaceuticals, INC. | $709.41 | 2021-2025 | Ultomiris, Soliris |
| Biohaven Pharmaceuticals, INC. | $536.43 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $483.55 | 2021-2025 | Zeposia |
| Lundbeck LLC | $434.30 | 2021-2025 | Vyepti |
| Emd Serono, INC. | $427.16 | 2021-2025 | Mavenclad |
| Pfizer INC. | $372.05 | 2023-2025 | |
| Eisai INC. | $339.90 | 2021-2025 | |
| Genzyme Corporation | $336.01 | 2021-2025 | |
| Argenx US, INC. | $282.33 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $277.15 | 2022-2025 | Vumerity, Tysabri, Skyclarys |
| Tg Therapeutics, INC. | $257.20 | 2024-2025 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $236.32 | 2024-2025 | Ponvory |
| Amgen INC. | $229.83 | 2021-2025 | Uplizna |
| Neurocrine Biosciences, INC. | $227.75 | 2021-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $226.42 | 2023-2025 | Rexulti, Nuedexta |
| Lilly USA, LLC | $224.10 | 2024-2025 | Mounjaro, Kisunla, Emgality |
| Neurelis, INC. | $169.63 | 2021-2024 | Valtoco |
| Livanova USA, INC. | $158.75 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Acadia Pharmaceuticals INC | $158.74 | 2024-2025 | Nuplazid |
| Genentech USA, INC. | $155.56 | 2021-2025 | Ocrevus Zunovo, Ocrevus |
| Kyowa Kirin, INC. | $155.11 | 2021-2024 | Nourianz |
| Amneal Pharmaceuticals LLC | $152.87 | 2021-2025 | Crexont |
| Biohaven Pharmaceutical Holding Company LTD. | $151.39 | 2022 | |
| Axsome Therapeutics, INC. | $149.43 | 2025 | Symbravo |
| Boston Scientific Corporation | $139.99 | 2025 | Watchman Flx |
| Novo Nordisk INC | $132.81 | 2022-2023 | |
| Ultragenyx Pharmaceutical INC. | $124.56 | 2025 | |
| Inari Medical, INC. | $113.46 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Impel Pharmaceuticals INC. | $113.40 | 2023 | Trudhesa |
| Daiichi Sankyo INC. | $113.40 | 2024 | Injectafer |
| Tactile Systems Technology INC | $104.38 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Celgene Corporation | $85.07 | 2022-2025 | Zeposia |
| Sk Life Science, INC. | $85.04 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $81.76 | 2021-2022 | |
| Tanabe Pharma America, INC. | $73.34 | 2022-2024 | |
| Banner Life Sciences, LLC | $70.58 | 2022 | |
| Csl Behring | $69.70 | 2025 | Hizentra |
| Novartis Pharmaceuticals Corporation | $64.92 | 2022-2023 | |
| Verona Pharma, INC. | $62.43 | 2025 | Ohtuvayre |
| Mdd US Operations, LLC | $61.22 | 2023-2024 | Gocovri, Apokyn, Gocovri |
| Merz Pharmaceuticals, LLC | $58.67 | 2025 | Xeomin, Ampyra, Inbrija |
| Astrazeneca Pharmaceuticals LP | $57.58 | 2021-2025 | Wainua |
| W. L. Gore & Associates, INC. | $46.50 | 2022 | |
| Virtus Pharmaceuticals LLC | $42.84 | 2025 | Levorphanol Tartrate |
| Jazz Pharmaceuticals INC. | $40.25 | 2022-2025 | |
| Adamas Pharmaceuticals, INC. | $30.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.40 | 2024 | Hyqvia |
| Upsher-Smith Laboratories LLC | $23.30 | 2021 | |
| Life Molecular Imaging LTD | $22.88 | 2025 | Neuraceq |
| Bioventus LLC | $22.59 | 2023 | Stimrouter Implantable Kit |
| Harmony Biosciences LLC | $18.11 | 2023 | Wakix |
| Greenwich Biosciences, INC. | $17.52 | 2021 | |
| Amylyx Pharmaceuticals, INC. | $16.72 | 2023 | Relyvrio |
| Janssen Biotech, INC. | $16.62 | 2025 | |
| Electronic Waveform Lab, INC. | $15.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.63 | 2021 | |
| Grt US Holding, INC. | $15.06 | 2021 | |
| Avion Pharmaceuticals | $14.57 | 2022 | |
| Ge Healthcare | $13.85 | 2022 | |
| Mallinckrodt Hospital Products INC. | $13.70 | 2021 | |
| Medtronic, INC. | $12.87 | 2022 | |
| Cycle Pharmaceuticals INC | $12.36 | 2024 | Ormalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.